Patients | Renal Function (Creatinine) | Pre-dialysis Ars Level | Post-dialysis Ars Level | Chelator | Mode of Dialytic Therapy | Dialytic Ars Clearance | Dialytic Ars Removal | Urinary Ars Clearance | Urinary Ars Removal | Outcome |
---|---|---|---|---|---|---|---|---|---|---|
Giberson [24] | 288 μmol/L Oliguric | 300 μg/L | 140 μg/L | BAL | HD 4 h | 87 ml/min | 3.36 mg over 4 h | n/a | 2.03 mg/day | Resolved GI symptoms and renal function recovered |
Vaziri [8] | 707 μmol/L | 411 μg/L | 364 μg/L | BAL | HD 4 h | 76 ml/min | 4.68 mg over 4 h | n/a | 3.12 mg/day | Resolved GI symptoms and renal function recovered |
Smith [26] | Oliguric | 26.7 μg/L | 29.0 μg/L | BAL and Penicillamine | HP 2 h | n/a | n/a | Improved renal function and remained comatosed after 100 days | ||
29.0 μg/L | 36.2 μg/L | HD 2 h | ||||||||
21.7 μg/L | 22.7 μg/L | HD 3 h | ||||||||
18.9 μg/L | 21.5 μg/L | HP 3 h | ||||||||
Levin-Scherz [27] | 495 μmol/L Anuric | 190 μg/L | 62 μg/L | BAL | HD 4 h | n/a | 2.9 mg over 4 h | n/a | n/a | Died |
Mathieu [10] | 238 μmol/L Anurica | 249 μg/L | 133 μg/L | No chelator | HD 4 h | 85 ml/min | 8.2 mg over 4 h | n/a | 10.7 mg | Renal function recovered |
110 μg/L | 91 μg/L | BAL | HD 4 h | 87.5 ml/min | 5.3 mg over 4 h | n/a | 13.2 mg | |||
1 – Blyth [25] | Oligurica | 80 μg/L | n/a | BAL | HD | 358 ml/min | 94 mg/72 h | Renal function recovered | ||
2 | Oliguric | 340 μg/L | n/a | BAL | CVVH | 15 ml/min | 23 mg over 90 h | 3.83 ml/min | 6 mg/99 h | Died |
Fesmir [28] | Normal | 444 μg/L | 170 μg/L | BAL and Penicillamine | HD | n/a | n/a | n/a | 24 mg/day | Developed PN and HT |
Hanston [29] | 459 μmol/L Oliguric | n/a | n/a | BAL + DMSA IV 2 days → DMSA IV 9 days | HD | 37.5 ml/min | 26 mg over 11 days | 1.34 ml/min | 15 mg over 11 days | Died |
CVVH | 0.64 ml/min | 8 mg over 11 days | ||||||||
DMSA IP 11 days | PD | 4.28 ml/min | 17 mg over 11 days | |||||||
Zilker [11] | Normal | 245 μg/L | 2.3 μg/Lb | DMPS | HD 5 h | n/a | 0.168 mg | n/a | 89.67 mg over 87 h | Recovered |
CAVHDF | 0.061 mg | |||||||||
HD 5 h | 0.12 mg | |||||||||
Lai [14] | Anuric | 730 μg/L at autopsy | n/a | BAL DMPS | HD | n/a | 2.04 mg | Died | ||
1 – Adam [30] | 406 μmol/L Oliguric | 558 μg/L | n/a | BAL | HD-HP 3.5 – 4 h | 55.7 – 70.4 ml/min | 3.8 – 5.2 mg per session | 37.1 ml/min | 156 mg over 20 days | Paraplegic |
PD | 2.83 mg over 6 days | |||||||||
2 | 247 μmol/L Oliguric | 540 μg/L | n/a | BAL | HD-HP 3.5 h | 125.8 ml/min | 11.62 mg per session | 8.54 mg over 34 h | Died | |
3 | 274 μmol/L Oliguric | 620 μg/L | n/a | BAL DMPS | HD-HP 3.5 h | 47.3 – 54 ml/min | 2.28 – 2.89 mg per session | 68 ml/min | 123.4 mg over 4 days | Died |
4 | Normal | 245 μg/L | n/a | DMPS | HD 5 h | 40 ml/min | 0.24 mg | 696 ml/min | 86.25 mg over 3 days | Fully recovered |
CAVHDF | 32.1 – 54.7 ml/min | 0.063 mg over 6 h and 0.051 mg over 12 h | ||||||||
5 | Normal | 2240 μg/L | n/a | DMPS | Nil | n/a | n/a | 183 - 436 ml/min | 134.6 mg over 4 days | Fully recovered |
6 | 901 μmol/L Anuric | 4469 μg/L | n/a | DMPS | HDF 5 h | 42.2 - 140.3 (average 98) ml/min | 252 mg over 6 sessions | Anuric | Fully recovered |